InvestorsHub Logo
Followers 104
Posts 2500
Boards Moderated 0
Alias Born 12/02/2016

Re: KS46268 post# 53609

Wednesday, 01/24/2018 3:37:02 PM

Wednesday, January 24, 2018 3:37:02 PM

Post# of 94910
As I understand it, the MCC is the governmental agency that will be issuing the medical marijuana manufacturing licenses.

So in knowing that the South African government is back in session as of January 23, we are then to understand that the MCC will be resuming the work they had prior to their recess. Shouldn't be much longer, as all the pieces are in place from a legislative standpoint:

http://www.mccza.com/documents/2674952b2.44_Cannabis_cultivation_Sept17_v2.pdf

In addition, the Medicines Act allows the MCC to issue a licence to manufacture either a medicine or a Scheduled substance (Active Pharmaceutical Ingredient/API). Section 22C(1)(b) of the Medicines Act enables the cultivation and manufacture of Scheduled substances and ensures the required oversight of the MCC in regulating these activities. This provision allows the MCC to license cultivators of Cannabis for medicinal use and enables regulatory oversight in a way that is compliant with South Africa’s international obligations.